Related Experiment Video

Updated: May 29, 2026

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
06:23

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity

Stéphane P Poulin1, Rebecca Dautoff, John C Morris

  • 1Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. spoulin@nmr.mgh.harvard.edu

Psychiatry Research
|September 17, 2011
PubMed

Insights

Amygdala atrophy in Alzheimer's disease (AD) is comparable to hippocampal atrophy in early stages. This brain change correlates with cognitive decline and neuropsychiatric symptoms, highlighting its clinical significance.

Area of Science:

  • Neuroimaging
  • Neurology
  • Alzheimer's Disease Research

Background:

  • Medial temporal lobe structures are crucial in Alzheimer's Disease (AD).
  • Amygdala atrophy's role and clinical impact in early AD remain under-investigated.
  • Previous research primarily focused on hippocampal atrophy in AD.

Purpose of the Study:

  • To quantify and compare amygdala atrophy with hippocampal atrophy in early AD.
  • To investigate the relationship between amygdala atrophy and cognitive function.
  • To explore the association between amygdala atrophy and neuropsychiatric status in AD.

Main Methods:

  • Utilized magnetic resonance imaging (MRI) to assess brain structure.
  • Analyzed two large cohorts (n=90 and n=174) of very mild and mild AD patients.
  • Employed linear regression analyses to examine relationships with cognitive and neuropsychiatric measures.

Main Results:

  • Amygdala atrophy levels were comparable to hippocampal atrophy in both AD samples.
  • Amygdala atrophy significantly predicted cognitive scores (Mini Mental State Examination, MMSE) and Clinical Dementia Rating Sum of Boxes (CDR-SB).
  • Aberrant motor behavior, anxiety, and irritability showed relationships with amygdala atrophy.

Conclusions:

  • Amygdala atrophy is as significant as hippocampal atrophy in early Alzheimer's Disease.
  • Amygdala atrophy is linked to global disease severity and cognitive impairment.
  • Specific associations between amygdala atrophy and neuropsychiatric symptoms warrant further research.

More Related Videos

A Comprehensive Protocol for Manual Segmentation of the Medial Temporal Lobe Structures12:30

A Comprehensive Protocol for Manual Segmentation of the Medial Temporal Lobe Structures

Published on: July 2, 2014

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Role of Amygdala in Memory01:16

Role of Amygdala in Memory

The amygdala is a small, almond-shaped structure responsible for processing and storing memories, particularly those linked to emotions like fear and stress. It plays an essential role in the brain's response to emotionally significant events and often enhances memory formation by triggering stress hormone release. The amygdala is vital for encoding and retrieving memories associated with fear or stress, a process that is adaptive by helping organisms avoid dangerous situations.
One of the...
Functional Brain Systems: Limbic System01:15

Functional Brain Systems: Limbic System

The limbic system, often called the "emotional brain," is a complex set of structures located deep within the brain. The intricate network of the limbic system supports a wide range of psychological functions, from emotional regulation to memory formation and sensory processing. This functional brain region encompasses specific parts of the diencephalon and the cerebrum, integrating the higher mental functions of the cerebral cortex with the primitive emotional responses of the deep brain...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...